نتایج جستجو برای: cutaneous malignant melanoma

تعداد نتایج: 296810  

Journal: :Archives of ophthalmology 2003
Ramin Monshizadeh Rebecca E Sands Wilfredo C Lara William Driebe

Ophthalmology. 5th ed. Baltimore, Md: Williams & Wilkins; 1998:2497-2551. 2. Whitcup SM, Vistica BA, Milam AH, Nussenblatt RB, Gery I. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol. 1998;126:230237. 3. Marmor MF, Zrenner E. Standard for clinical electroretinography (1999 update). Doc Ophthalmol. 1998;97:143-156. 4. Crum CP. Germ cell tum...

2010
Rafaela Nogueira Moreira Cassio Roberto Rocha Santos Nadia Lages Lima Flaviana Dornela Verli Sandra Aparecida Marinho

UNLABELLED Melanomas are malignant lesions stemming from the disorganized proliferation of melanocytes. This condition is more common on skin, but may also be detected in mucosa, such as in the oral cavity. The aim of the present study was to report similarities and differences between oral and cutaneous melanoma. KEYWORDS Melanoma; Skin; Mouth; Diagnosis.

Journal: :Experimental oncology 2017
I Savarese M Grazzini A Gori A D'Errico L Doni F Scarfì P Covarelli F Di Costanzo V De Giorgi

The malignant melanoma is a neoplasm associated with a wide variety of cutaneous paraneoplastic syndromes, as dermatomyositis, systemic sclerosis, paraneoplastic pemphigus. We describe a case of four multiple trichilemmal cystis arising on frontal region in the same patient with brain metastasis and unknown primary melanoma and discuss their relationship.

2013
Z. Ali N. Yousaf J. Larkin

Melanoma is a cancer arising from the malignant transformation of melanocytes. These pigment-producing cells derive embryologically from pluripotent neural crest stem cells. During foetal development they not only predominantly migrate to and differentiate within the epidermis, but also to other extra-cutaneous pigment-containing sites such as the eyes, meninges, oesophagus and mucous membranes...

2017
Toshihiko Matsuo Osamu Yamasaki

A patient with metastatic cutaneous malignant melanoma developed Vogt-Koyanagi-Harada disease-like posterior uveitis after two nivolumab (anti-PD-1 antibody) injections. Vogt-Koyanagi-Harada disease, with the background of autoimmunity against choroidal melanocytes, suggests nivolumab be working by disintegrating inhibition circuit of T cells against a common epitope shared between melanoma cel...

Journal: :Cancer biomarkers : section A of Disease markers 2010
Thomas Bogenrieder Meenhard Herlyn

Cutaneous melanoma is a highly aggressive cancer with still limited, but increasingly efficacious, standard treatment options. Recent preclinical and clinical findings support the notion that cutaneous melanoma is not one malignant disorder but rather a family of distinct molecular diseases. Incorporation of genetic signatures into the conventional histopathological classification of melanoma a...

2006
D M King A Gillams L Ollivier S Gerber D Vanel H Brisse J Leclère K McHugh D Vanel S Bonvalot A Le Cesne C Le Péchoux W Schima L H Schwartz R M Gore

Cutaneous cancer is now the most common human malignancy and in the UK 11% of that total is due to malignant melanoma of which probably 80% is related to increased exposure to sunlight. Although it is the least common skin cancer malignant melanoma is the most deadly, and in 1999 it killed over 1600 individuals in the UK. In 2004, in the USA, 55 100 new cases were anticipated. The incidence of ...

Abed-Ali Ziaee, Parisa Mousavi-Shafaei, Uwe Zangemeister-Wittke,

Background: Malignant melanoma is a highly metastatic cutaneous cancer and typically refractory to chemotherapy. Deregulated apoptosis has been identified as a major cause of cancer drug resistance, and upregulated expression of the inhibitor of apoptosis protein melanom, an inhibitor of apoptosis (ML-IAP) is frequent in melanoma. Methods: Based on the conclusion that ML-IAP expression contribu...

Journal: :thrita 0
amirpasha ebrahimi department of surgery, hepatobiliary and liver transplantation division, imam-khomeini hospital, tehran university of medical sciences, tehran, ir iran afshin abdi rad department of surgical pathology, cancer institute, imam-khomeini hospital, tehran university of medical sciences, tehran, ir iran massoome najafi department of surgery, cancer institute, imam-khomeini hospital, tehran university of medical sciences, tehran, ir iran; department of surgical pathology, cancer institute, imam-khomeini hospital, tehran university of medical sciences, tehran, ir iran. tel/fax: +98-2166581657

introduction primary malignant esophageal melanoma makes up 0.1% to 0.2% of all esophageal malignancies. most physicians assume malignant melanoma as a skin originated neoplasm, however this type of melanoma can occur anywhere in the gastrointestinal tract especially in the esophagus. thus, it is essential to consider malignant melanoma in differential diagnosis of any esophagus masses. case pr...

2012
Edibaldo Silva

Recently, a Surveillance Epidemiology and End Results (SEER) survey of melanoma patterns of care by the Mayo Clinic, Scottsdale showed remarkable deviations from best practice patterns throughout the country. The study, which analyzed the SEER records of 35,126 stage I to III cutaneous malignant melanoma patients treated from 2004 to 2006, showed that adherence to National Comprehensive Cancer ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید